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ABSTRACT
Audiogenic seizures (AGS) in genetically
epilepsy-prone rats (GEPR) of the moderate-
seizure substrain (GEPR-3s) were investigated
to determine whether norepinephrine (NE)
depletion induced by 6-hydroxydopamine (6-
OHDA) microinfusion into the locus coeruleus
(LC) could alter the efficacy of intraventricular
NE tissue grafts in promoting reductions in
seizure severity in AGS. GEPR-3s were
stereotaxically infused with 6-OHDA
(4pg/side/rat), or vehicle into the region of the
LC. Following 6-OHDA treatment all animals
were subjected to 3 AGS tests. GEPR-3s seizure
severities were increased in 39.5% of the
animals after microinfusion of 6-OHDA into the
region of the LC. Following the third AGS test,
each rat was stereotaxicaily implanted with 17
gestational day rat fetal tissue obtained from the
dorsal pons and containing the primordia of the
LC or with tissue obtained from the neocortex
or were sham-grafted. Subsequent to grafting,
rats were subjected to 3 additional AGS tests.
53% (10/19) of 6-OHDA treated GEPRs showed
a significant reduction in seizure severity
following transplantation of fetal LC tissue. In
contrast, only 20% (1/5) of GEPRs infused with
saline rather than 6-OHDA showed a reduction
of seizure severity following fetal LC
transplantation. NE content in the cortex and
pons/medulla was decreased by 78% and 46%
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respectively following 6-OHDA microinfusion
into the LC. Prominent grafts with numerous
TH positive neurons and neurites were present
within the third ventricle of grafted animals,
while cortex grafts contained no TH
immunostained structures. These findings
suggest that the efficacy of fetal LC tissue to
promote reductions in seizure severity in GEPRs
is increased following depletion of central NE by
microinfusion of6-OHDA.
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INTRODUCTION
Therapeutic potential in transplantation
neurobiology is being explored in several animal
models of neurological disorders including models
of Parkinson’s disease/17,28,31,39/, Huntington’s
disease /13,18/, Alzheimer’s disease /33,35/, and
epilepsy /1,10,11,25/. For Parkinson’s disease,
progression of research on the potential beneficial
effects of neurotransplantation has entered, perhaps
prematurely /15,34/, the human clinical arena
/24,26/. The hypothetical potential of neuro-
transplantation as a therapeutic approach to several
neurological disorders is appreciable.
The genetically epilepsy prone rat (GEPR)
represents a natural animal model of epilepsy/19/.
Currently, there are two independently derived
strains of GEPR: GEPR-3s which consistently
display an audiogenic seizure (AGS) score of 3, and
GEPR-9s which consistently display an AGS score
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of9 according to the seizure-rating scale developed
by Jobe /20/. GEPR-3s have running-bouncing
donic seizures and GEPR-9s exhibit severe tonic
seizures with full hindlimb extension. Seizure
predisposition in these animals is manifested by
enhanced susceptibility to a variety of seizure-
invoking stimuli, including sound, heat, convulsive
drugs and electroshock/9,32/. The basis of seizure
predisposition and the determinants of severity of
seizures experienced by GEPRs are presently
unknown, but are hypothesized to result from
regionally-specific aberrant neurotransmitter
profiles in the brains ofthese animals/14,21/.
The noradrenergic neurotransmitter system
appears to serve as a determinant of seizure severity
in the GEPR brain /20,23/ and pharmacological
evidence supports the hypothesis that there is an
inverse relationship between AGS severity and the
concentration of norepinephrine (NE) in the
synaptic clet. Treatments that decrease the
availability of NE at its receptors enhance both
seizure susceptibility and severity in the GEPR. For
example, drugs which deplete brain NE by
interfering with the vesicular storage (i.e., reserpine)
are demonstrated to cause an increase in seizure
severity /20/. Inhibition of NE synthesis plus
displacement of NE from its storage vesicle can
further intensify AGS/20/. Similarly, inhibition of
NE synthesis coupled with cold stress to produce
depletion ofNE also will increase AGS severity in
GEPRs /20/. We and others have reported that
depletion of central NE using the catecholaminergic
neurotoxin, 6-hydroxydopamine (6-OHDA),
increases the severity of seizures in a significant
percentage of GEPR-3s /5,8/. Conversely,
treatments that are designed to increase the
concentration ofNE at its receptors appear to exert
anticonvulsant effects on AGS. For example,
excessive formation of NE by precursor (L-dopa)
administration is known to reduce seizure intensity
in GEPRs /22/, and blocking re-uptake of NE,
which leads to an increase in synaptic clett NE
concentration, also reduces seizure severity in the
GEPR /20,21/. Widespread decrements in NE
content are found in GEPR brains /21/ and
deficiencies in NE are present in naive (i.e., never
having experienced a seizure) GEPRs as well as
premature GEPRs (15 days of age) prior to
development of seizure susceptibility /12/. These
data suggest that the deficiency in NE content is
due to an innate disorder and not to the seizuresper
se. Clearly, there exists a deficiency in the
noradrenergic system which parallels propensity for
seizures in the GEPRs/20,21/.
We have previously reported that transplantation
of fetal tissue containing the locus coeruleus (LC), a
pontine nucleus where the majority of brain NE is
synthesized, into the third ventricle results in a
reduction in seizure severity in a limited number of
GEPR-9s and GEPR-3s/11/. Immunohistochemical
analyses of the grafted animals in this study/11/
revealed an abundance of neurons staining for
tyrosine hydroxylase (TH, the rate-limiting enzyme
in catecholamine biosynthesis) within the grafted
tissue. Other investigators/1,25/ have shown that
fetal LC gratis can effectively reduce seizure
susceptibility in rats whose susceptibility to kindled
seizures was increased by prior NE depletion.
Moreover, functional responsiveness of LC tissue
gratis has been demonstrated during kindled
seizures /2/. In another model, the induction of
seizures by pentylenetetrazol in fimbria-fornix
lesioned animals is facilitated by grafting
acetylcholine-rich basal forebrain cell suspensions
into the hippocampus /10/. These studies
/1,2,10,11,25/ clearly demonstrate the modulatory
potential of fetal grats in three distinct models of
epileptiform activity.
There is evidence which suggests that the degree
of integration between fetal grafts and host animals
may in part depend on a synaptic void in the host
animal/29/. For example, NE axons from fetal LC
grafts in the anterior chamber of the eye
hyperinnervate co-grafts of hippocampal tissue
when the host superior cervical ganglion (SCG) is
lesioned/29/. Typically, axons from the host SCG
invade and innervate intraocular-gratted hippo-
campal tissue; however, when the SCG is lesioned,
there is a resulting synaptic void in the grafted
hippocampus. Without competition from host NE
fibers from the SCG, co-grafts of fetal LC innervate
the hippocampal co-grafts withNE axons to a much
greater extent/29/. Additionally, it has been shown
that neurite outgrowth in vitro from
catecholaminergic explant cultures is much reduced
in the presence of exogenously administered L-
dopa, a precursor of NE /36/. These findings
support the hypothesis that there is a type of
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feedback inhibition on neurite outgrowth and axon
aborization from fetal grafts in the presence of
synaptic competition or neurotransmitter feedback
from the host. Therefore, inasmuch as LC gratis
have been shown to reduce seizure severity in
limited numbers of GEPR-9s and GEPR-3s /11/,
NE depletion has resulted in increased propensity
for seizures in rats/5,8/and fetal gratis have been
shown to exhibit greater neurite growth in the
absence of synaptic competition /29/, the present
study was designed to determine whether the
incidence of reduced seizure severity following
neurotransplantation of fetal noradrenergic neurons
could be increased in GEPR-3s after depletion of
brain NE.
MATERIALS AND METHODS
Animals
Adult male genetically epilepsy-prone rats
(GEPRs) were obtained from the colony at the
University of Illinois College of Medicine, Peoria
(Peoria, IL). After arrival, each rat was pretested on
three separate occasions for audiogenic-induced
seizures (AGS) to confirm that they were GEPR-3s.
The seizure severity was scored using the seizure-
rating scale described by Jobe/20/, which assigns
scores from 0 (no seizure) to 9 (generalized tonic-
seizure with complete hindlimb extension) with each
score above 0 representing an increasingly severe
seizure. GEPR-3s display seizures characterized by
two running phases culminating in clonus of the
forelimbs and hindlimbs. Testing for AGS involves
placing each rat into a round (40 cm) Plexiglass
arena and exposing them to a bell tone of 100 db
intensity for 60 seconds. This procedure induces
consistent seizures of intensity 3 in GEPR-3s and 9
in GEPR-9s. Only GEPR-3s were used in the
present study. The latency to onset of running
behavior and convulsion was timed and the seizure
severity was scored and recorded for each rat.
Experimental protocol
After preliminary AGS-testing of each rat for
confirmation of seizure display, rats were divided
into the following two groups" 6-OHDA
microinfused (n=38), and saline microinfused (n=7).
Animals from each of these two groups were
subsequently divided into the following subgroups"
6-OHDA-infused, LC-grafted (n=19); 6-OHDA-
infused, cortex-gratted (n=10); 6-OHDA-infused,
sham-grafted (n=9); saline-infused, LC-grafted
(n=5); saline-infiased, sham-gratted (n=2). The
timing of pretests, microinfusions, post-micro-
infusion tests, grafting and post-grafting tests are
shown in schematic form in Figure 1. Briefly,
animals were pretested upon delivery to insure that
they were GEPR-3s. After pretesting, rats were
microinfused with either saline or 6-OHDA as
described below. Atter microinfusions, animals were
again tested on three separate occasions to
determine whether seizures were more severe than
the pretest seizure scores. After the third test,
animals received grafts from either the fetal LC, the
fetal neocortex, or were sham-grafted. Atter
grafting, animals were again AGS tested three times
to determine whether gratting would alter the
severity of seizures atter central noradrenergic
depletion. At the end of the study, animals were
processed for either general histology (n=20) with
morphometric measurement of graft sizes,
neurochemistry (n=14) or immunocytochemistry of
tyrosine hydroxylase (n 11) as described below.
NE depletion
Following pretesting, animals were anesthetized
with chloral hydrate (400 mg/kg, i.p.) and subjected
to bilateral stereotaxic microinfusion of 6-
hydroxydopamine (6-OHDA, Sigma Chem., St.
Louis, MO; 4lag/side in 0.5 tl vehicle) or vehicle
(0.09% saline, 0.1% ascorbic acid) into the LC
using a Harvard infusion pump. Coordinates for
microinfusions were taken from a rat brain atlas/14/
and were: anterior-posterior from the interaural line
(IAL) -2.3 mm; lateral from midline 1.2 mm;
ventral from dura -6.6 mm.
Grafting
Following decapitation of pregnant Sprague-
Dawley rats, uteri containing pups (17 days
gestation) were removed and placed into a Petri
dish containing a balanced salt solution (Hank’s,
GIBCO Labs, Grand Island, NY) on ice. Under a
dissecting microscope, each fetal brain was removed
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6-OHDA microinfusion
into Locus Coeruleus
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fetal LC or Ctx tissue
AGS Pretests
(mean of 3)
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Fig. 1:
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Temporal sequence ofexperimental procedures for the present study. First, a series of 3 audiogenic seizure pretests were
evaluated in order to confirm that the animals were GEPR-3s. The means ofthese three tests are represented as AGS test
number 1. Following these tests, animals were infused with 6-OHDA directly into the LC. A series of three AGS post
tests were evaluated at 2, 3 and 4 weeks after 6-OHDA. After the fourth test, animals were subjected to ICV gralng of
fetal LC or CTX tissue or were sham grafted. Subsequent to grafting, rats were again AGS tested three times at 4, 8 and
12 weeks after grafting.
and the anterior lip of the pontine flexure on each
side or small pieces of occipital cortex were excised
similar to the surgical procedure described by
Bj6rklund /3/. Fetal tissues were aspirated into
spinal needles for subsequent transplantation. Adult
GEPR-3 hosts were anesthetized with chloral
hydrate (400 mg/kg, i.p.) for neurosurgery. After
reflection of the scalp and drilling a small burr hole
through the calvaria, a spinal needle containing fetal
LC or cortex tissue was stereotaxically directed into
the third ventricle using coordinates: AP=7.0 from
IAL; L=0 from midline; V=9.0 from dura; incisor
bar set at -3.3 mm/30/. Tissue was pressure ejected
very slowly (over a 5 minute interval). Sham grafts
consisted of an identical infusion of the balanced
salt solution into the third ventricle. After infusion,
the spinal needle was leg in place for 5 minutes
before removal. The burr hole was then covered
with gelfoam, and the scalp sutured with 9 mm
wound clips. After surgery, GEPRs were allowed to
recover under supervision.
Immunohistochemistry
Subsequent to final AGS testing, the brains of 11
rats from either the 6-OttDA/LC grafted, the
saline/LC graRed or the 6-OHDA/ctx grafted
groups were subjected to immunohistochemistry to
determine whether noradrenergic neurons were
present in the grafted tissue. Rats were deeply
anesthetized with sodium pentobarbital (50 mg/kg,
i.p., Butler labs, Columbus, OH) and transcardially
perfused with phosphate buffered saline (PBS, pH
7.4) followed immediately by perfusion of 200 ml,
ice-cold paraformaldehyde (4%) in PBS. Brains
were removed and post fixed in fixative for 1.5 h,
and transferred to cold 25% sucrose for 48 h.
Brains were sectioned at 40 tm thickness on a
cryostat and free-floating sections were immuno-
histochemically processed for localization of
tyrosine hydroxylase (TH) using a biotin-avidin
method (ABC kit, Vector Labs, Torrence, CA). A
polyclonal primary antiserum for TH was obtained
from Eugene Tech Int. (Allendale, NJ) and used at a
dilution of 1/15,000 (in 0.1M PBS, 0.1% Triton-X,
0.1% BSA, pH 7.4). After 48 h incubation at 4C
and subsequent processing with the ABC kit, the
reaction was visualized using 3,3’-diaminobenzidine
tetrahydrochloride in the presence of hydrogen
peroxide. The presence of TH-positive neuron
somata and fibers in the host and gaffed tissues was
recorded for each animal so processed.
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NE determination
Norepinephrine content was measured in order
to assess the degree of depletion of central NE
following 6-OHDA or saline microinfusion. In 14
animals not used for immunohistochemistry, the
content ofNE in the brains of6-OHDA treated and
control rats was determined by high performance
liquid chromatography (HPLC) with electro-
chemical detection. Brain regions were dissected on
an ice-cold plate, wrapped in aluminum foil and
frozen in liquid nitrogen until assay. The
pons/medulla was isolated as a representative
brainstem sample and the cerebral cortex was
isolated as a representative forebrain sample. Brain
samples were homogenized in 4 ml 0.2N perchloric
acid (PCA) containing 80 ng/ml 3,4-dihydroxy-
benzylamine (DHBA) and transferred to glass
centrifuge tubes. After centrifugation, 2.0 ml of the
supematant from each sample was shaken with 10
ml of 0.5 M TRIS buffer (pH 8.6) containing 50 mg
of acid-washed alumina and 10 gl of sodium
metabisulfate. After centrifugation and removal of
the supernatant, the alumina was washed with 1.0
ml TRIS buffer (pH 7.0). Finally, the NEwas eluted
from the alumina by shaking in the presence of 0.5
ml 0.2N PCA for 20 min. The eluate was then
centrifuged at 13,000 g for 3 min and 50 gl was
injected into a rheodyne injector connected to a
bioanalytical HPLC system. The concentration of
NE was determined by comparing peak heights of
NE in samples to those ofNE in standards (20 to 80
ng/ml) run through the assay simultaneously. The
HPLC system consisted of a 5 lam biophase C18
reverse-phase column (15 cm by 4.6 cm, Beckman)
and a glassy carbon electrode with the applied
potential set at 460 mV vs a Ag/AgC1 reference
electrode. The mobile phase contained citric acid
(14.6 mM), Na2HPO4 (4.9 mM), octane sulfonate
(100.8 mM) and ethylenediaminetetraacetic acid
(EDTA, 55.3 mM) in 3.0% methanol.
changes in seizure severity preceding and following
gratting treatments was analyzed by a contingency
table analysis. Differences in NE content in either
the cortex or the pons-medulla ofrandomly selected
animals were analyzed by Student’s t-test. The
presence ofTH positive perikarya and fibers within
grained LC tissues of selected animals was noted.
Comparisons of gratt sizes between Ctx and LC
tissue grafts were made by Student’s t-test.
RESULTS
NE content after 6-OHDA infusions
NE content in the brainstem and cerebral cortex
is shown in Figure 2. There was a 78% reduction of
NE in the forebrain (p<0.05) and a 46% reduction
of NE in the brainstem (p<0.05) of animals
receiving an LC microinfusion of 6-OHDA.
600
400
200
Ports/Medulla
Control
Cerebral cortex 6-OHDA
6-OHDA
Control
Data analysis
Statistical analysis of changes in seizure severity
was carried out using non-parametric tests. The
incidence of changes in seizure severity following
microinfusions of 6-OHDA or saline was analyzed
by a coded chi-squared test. The incidence of
Fig. 2: The concentration of norepinephrine in the cerebral
cortex and the combined pons/medulla in animals
treated with intra-LC, 6-OHDA or saline. NE
content was significantly reduced in both the cortex
and the pons/medulla in rats receiving 6-OHDA.
(Mean + S.E.M. *=difference between controls and
6-OHDA group in each respective brain area,
p<0.05.)
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Although only about 40% of the animals treated
with 6-OHDA experienced a subsequent increase in
seizure severity (see below), all of the examined
brains of6-OHDA treated animals were consistently
depleted ofNE (Fig. 2).
Histology of grafts
An example of an LC graft in an animal of the
present study is shown in Figure 3. Immuno-
histochemical examination of grafted brains
revealed that LC grafts within the third ventricle
contained numerous TH positive perikarya and
dense plexuses of TH positive fibers while Ctx
grafts were devoid ofTH positive profiles. In some
of the LC grafted animals, the cytoarchitexture of
TH positive areas within the grafts resembled that
of the LC in situ. LC or Ctx gratis were found in
the third ventricle of all 11 rats analyzed with
immunohistochemistry (ICC) and all the LC gratis
analyzed by ICC were found to contain numerous
TH-positive somata and neurites. A morphometric
analysis was conducted on 5 cortical-tissue grafts
and 8 LC-tissue grafts from gratted animals not
processed for ICC or neurochemistry. Gratis
derived from the occipital cortex were significantly
larger than those from the region ofLC (Table 1).
Seizure scores
There were four typical behavioral responses
across the treatment groups: 1) rats which displayed
an increase in seizure severity following 6-OHDA
microinfusion, and a subsequent reduction in seizure
severity following grafting (Figure 4a). This
response was called exacerbated/corrected; 2) rats
which demonstrated an increase in seizure severity
following 6-OHDA microinfusion with no reduction
in seizure severity following grafting (Figure 4b).
This response was called exacerbated/noncorrected;
3) rats which showed no increase in seizure severity
after 6-OHDA treatment, but who did show a
reduction in seizure severity atter grafting (Figure
4c). This response was called nonexacerbated/
corrected; and 4) rats which demonstrated no
increase in seizure severity following 6-OHDA
microinfusion and no reduction in seizure severity
atter grafting (Figure 4d). This response was called
nonexacerbated/noncorrected. The number of
animals in each treatment group displaying each of
these four responses are indicated in Table 2. With
reference to change in seizure severity following
microinfusions of 6-OHDA into the LC, 15 of the
38 animals (39.47%) displayed a significant increase
in seizure severity following 6-OHDA treatment
(p<0.0418). In the control group, 0 of the 7 had
altered seizure severity following saline micro-
infusion. Figure 5 shows the percentage of animals
in which grafting resulted in a reduction of seizure
severity. As shown in Figure 5, only 1 of the 10
GEPR-3s microinfiased with 6-OHDA and
transplanted with cortex tissue showed a decrease in
seizure severity subsequent to grafting. Similarly, 1
out of 9 6-OHDA microinfused and sham-
transplanted GEPR-3s showed a slight decrease in
seizure severity atter surgery. The difference in the
incidence of change of seizure severity between the
cortex- and sham-transplanted groups was not
significant (p=0.5957). In contrast, 53% (10/19) of
the 6-OHDA treated animals transplanted with fetal
LC tissue showed a significant decrease in seizure
severity after transplantation. The incidence of
change in seizure severity of the LC transplanted
group compared to the cortex- and sham-treated
groups was significant (p<0.0167). Of the 5 saline-
infused GEPR-3s transplanted with LC tissue, no
rats showed increased severity following saline
microinfusion; however, 1 of 5 LC-transplanted rats
showed a marked reduction in seizure severity
following grafting of fetal LC. Finally, although the
incidence of reduction in seizure severity in LC
transplanted animals receiving 6-OHDA compared
to those receiving saline was not significantly
different (p>0.05), 53% (10/19) of the 6-OHDA
treated animals showed post-LC-gratting reductions
in seizure severity while only 20% (1/5) of saline
treated animals showed post-LC-gratting reductions
in seizure severity. Of the two rats microinfused
with saline and sham transplanted, there were no
effects of either treatment on seizure severity.
Figure 6 shows the actual degree of the seizure
reduction following LC gratting in 6-OHDA treated
rats. Panel A shows the data for all animals grafted
with fetal LC (n=19), while panel B shows data only
from those animals that had a reduction in seizure
severity following grafting (i.e., corrected animals
only, n=10). In both groups, the pretest score
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Fig. 3: Panel A shows a darkfield photomicrograph of a third ventricular graft of fetal LC at 16 weeks post-transplantation (45x
magnification). Panel B represents a camera lucida drawing of Panel A. The graft fills the majority of the third ventricle
except for the dorsal aspect (labeled V-3). Numerous tyrosine hydroxylase-positive neuron clusters (NC) were observed
in both the host and the grafted tissue. Panel C is an enlarged brightfield photomicrograph of a boxed insert in Panel A
(dotted rectangle labeled C). This photomicrograph shows typical neurons (arrows) within these neuron clusters. Panel
D is an enlargement of another boxed insert in Panel A (labeled D), which shows the host (h)-graft (g) interface,
depicted by the fine dotted line, immediately subjacent to the fasciculus retroflexus (fr) which is indicated by the heavy
dotted line. Numerous axons (small arrows) and one neuron (large arrow) are seen in Panel D (Panels C and D are
approximately 150x magnification).
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TABLE 1
Approximate sizes of cortical tissue (Ctx) or locus
coeruleus (LC)tissue grats within the third ventricle
(mean +/- S.E.M.)
Brain Cross sectional Antero/postero
region n area (inn2) diameter (Inn)
LC 8 516 + 70 455 +/- 67
Ctx 5 1,783 + 629* 730 + 137"
n number of rats analyzed (the number of sections of Ctx
and LC grafted animals were 73 and 91 respectively)
* p<0.05
means were 3. As shown in panel A, following 6-
OHDA, the seizure mean scores were significantly
elevated to 4.7 across all animals (however, only
39% were elevated in seizure severity, p<0.05).
After grafting, the mean seizure score of all animals
receiving LC grafts was 4.2 (again, this reflects that
only 53% of the animals were corrected in seizure
severity). The post-grafting scores were not
significantly different from either the pretest or the
post-6-OHDA treatment scores. Panel B shows the
degree of seizure severity reduction for those
animals that were corrected (n=10). The degree of
exacerbation of these animals was not as high as
{LC grafting}
{6-0 A}
3 4 5
Seizure Test Number
{6-OHDA} {LC grafting}
Seizure Tes Number
6 7 8
JOURNAL OF NEURAL TRANSPLANTATION& PLASTICITYNEURAL TRANSPLANTATIONAND SEIZURES 73
9
8
7
6
3
2
1
0
0
{6-OHDA} p
{CTX grafting}
[] []
1 2 3 4 5 6 7
Seizure Test Number
{LC grafting}
{6-OHDA}
0 1 2 3 4 5 6 7 8
Seizure Test Number
Four graphs (A-D) each representing an individual showing one of the four typical behavioral responses of rats
following 6-OHDA administration and fetal brain tissue grafting. The data in Panel A (representing animal GEPR-3, s2-
#3) showed an increase in seizure severity from a score of 3 to a score of 9 by the third test after 6-OHDA. This
represents an increase in severity from a moderate clonic seizure to a severe tonic-clonic seizure with full hindlimb
extension. Subsequent to grafting fetal LC, the severity of seizures was again reduced from a score of 9 to the previous
score of 3. Panel B shows the data from an animal (GEPR-3, sl-#2) who did not show an increase in seizure severity
after 6-OHDA but who did show a reduction in seizure severity from a pregraffing score of 3 to a score of 0, representing
a complete absence of seizure in response to the audiogenic stimulus. Panel C shows the data from an animal (GEPR-3,
s4-#16) who showed an increase in seizure severity following 6-OHDA treatment, but who did not show any reduction
in seizure severity up to 12 weeks following grafting of fetal cerebral cortex. Panel D shows the data from an animal
(GEPR-3, s3-#24) who did not show an increase in seizure severity following 6-OHDA, nor was there a reduction in
seizure severity following grafting.
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TABLE 2
Number ofanimals by treatment group which showed the following response patterns
Treatment Group (n) Ex Ex/Corr N-Ex/Corr Ex/N-Corr N-Ex/N-Corr
6-OHDA/LC (19) 9/19 4 6 5 4
6-OHDA/Ctx (10) 4/10 1 1 3 5
6-OHDA/Sham (9) 2/9 1 0 1 7
Saline/LC (5) 0/5 0 1 0 4
Saline/Sham (2) 0/2 0 0 0 2
Ex refers to exacerbated seizure severity following 6-hydroxydopamine (6-OHDA or saline), Corr refers to
corrected (reduced) seizure severity following grating (N-refers to non-).
The response patterns Ex/Corr, N-Ex/Corr, Ex/N-Corr, N-Ex/N-Corr correspond to representative
animals shown in Figure 4 A-D.
6O
50
40
30
20
10
6-OHDA LC graft
/ 6-OHDA Ctx graft
I 6-OHDA Sham graft
Saline LC graft
r"] Saline Sham graft
Treatment groups
The percentage of animals who showed a reduction in seizure severity subsequent to grafting or sham treatment. The
incidence of reduction in seizure severity was highest in the 6-OHDA, LC transplanted group (p<0.0167).
that for the entire group (n=l 9) due to the fact that
some of these animals were not exacerbated by 6-
OHDA yet all these animals’ seizure severity scores
were reduced following grafting (i.e., some to
below pretest values). Following grafting of LC,
seizure scores were significantly lower than both the
pretest and post 6-OHDA treatment scores
(p<0.05). Latencies to the onset ofrunning behavior
and convulsions were not altered subsequent to
brain infusions or transplantation in rats of any of
the groups.
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Fig. 6:
{n=19} {n=10}
pretest
post6ohda
postgraft
Seizure severity scores (mean of three separate tests + S.E.M.) in all LC grafted animals (n=19, Panel A) and those LC
grafted animals which showed a reduction in seizure severity following grafting (n=10, Panel B). In all animals, the
pretest score was 3. Panel A: Following 6-OHDA, the severity of seizure in all animals increased significantly from a
mean of 3 to 4.7 in the entire group (note, however, that only 39% of these animals were exacerbated following 6-
OHDA). The effects ofLC grafts on seizure severity across the entire group were not significant in that the scores after
grafting were not significantly different from those after 6-OHDA; however, these scores were also not different from the
pretest values (*=p<0.05 from pretest scores only, ANOVA [F2,18 5.06]). Panel B. In those 10 animals which showed
reduction in seizure severity, 6-OHDA significantly increased the severity of seizure from 3 to 4.2 (note, however, that
not all of these animals were exacerbated following 6-OHDA). After LC grafting, those 10 animals that were corrected
had significantly lower seizure severity scores than animals at pretest and following 6-OHDA (*p<0.05 from pretest and
post grafting; **p<0.05 from pretest and post 6-OHDA: ANOVA lF2,9 10.37]).
DISCUSSION
It is well documented that seizure severity in the
GEPR is inversely correlated with brain NE level
/14,20,21,23/. Previous studies in this laboratory/8/
and others/5/have demonstrated that depletion of
brain NE in normal rats and GEPR-3s using the
catecholamine neurotoxin 6-OHDA results in an
increase in seizure severity in a significant number
of these animals. In the present study, analysis of
NE content in the cortex, an area ofthe brain which
receives the majority of its noradrenergic terminals
from the LC, revealed that 6-OHDA microinfusion
into the LC caused a 78% reduction in cortical NE.
The 46% depletion ofNE content in the brainstem
as a result of microinfusion of6-OHDA into the LC
is also significant. It should be recognized that the
remaining catecholamine nuclei in the brainstem,
including those in the diffuse lateral tegmental
system, remain intact. The effectiveness of the LC
infusions is clearly demonstrated by the marked
depletion of NE (78%) in the terminal regions of
these neurons (i.e., the cerebral cortex). Although
the extent of NE depletion in terminals of LC
neurons innervating the brainstem following LC
lesion could not be dissected out, it is presumed that
it would be similar to the depletion of NE in the
cortex which is also innervated by the LC. Thus, in
light of the remaining catecholamine cell groups in
the brainstem, the 46% depletion following LC
microinfusion of 6-OHDA appears to represent a
rather large depletion of NE in those brainstem
terminal fields which originate in LC neurons. The
present data demonstrate that depletion of NE in
GEPR-3s following the microinfusion of 6-OHDA
into the LC is associated with an increase in the
severity of seizures in approximately 40% of
GEPR-3s. However, other studies in our laboratory
have shown a greater incidence of seizure
exacerbation (i.e., 50-70% of animals) following LC
infusions of 6-OHDA/8/. The reason for the lower
incidence of seizure exacerbation in the present
study compared to previous work/8/is unknown;
however, the degree of NE depletion between the
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studies was also different. In the present study, the
intra-LC microinfusion of 6-OHDA reduced the
content ofNE in the cortex by 78%, while in the
previous study /8/, cortical NE depletion was
approximately 90%. The differences between the
two studies in degree of central NE depletion after
intra-LC microinfusion of 6-OHDA may account
for the differences in the incidence of seizure
exacerbation. Additionally, because ofthe small size
of the LC as a target for microinfusion, differences
between studies in central NE depletion may have
resulted from subtle differences in location of the
cannula tip within the surround of the LC.
Interestingly, 6-OHDA-induced LC lesions have
also been shown to significantly increase the
severity of audiogenic-like seizures in normal rats
rendered susceptible to sound-induced seizures by
microinjection of N-methyl-D-aspartate (NMDA)
into the inferior colliculus/7/. In that study/7/, as in
the present one, some rats displayed a marked
depletion ofNE but failed to exhibit an increase in
seizure severity following 6-OHDA treatment. The
reason for this remains unknown, although it is
conceivable that NE depletion in a crucial region
not assayed per se is responsible for regulating
seizure predisposition in the GEPRs and NMDA
infused rats. Perhaps a better correlation between
NE depletion and seizure exacerbation would be
obtained should this hypothesized crucial region be
examined.
A number of studies have reported beneficial
effects of host NE or NE-tissue transplants on
seizure activity in other models of epilepsy or
epileptiform activity. Fetal LC cell suspensions
transplanted into the hippocampal formation of
adult rats suppress the onset and the progression of
kindling-induced epilepsy in rats made hyper-
sensitive to kindling by noradrenergic depletion
/1,25/. Hippocampal tissue gratis in the anterior
chamber of the eye are protected from epileptiform
activity induced by penicillin, when adrenergic
afferents to the gratis are activated /16/. Tonic
inhibitory neurotransmission, as assessed by
electrophysiology, can be reinstated in the
hippocampal formation following placement of fetal
LC gras into the hippocampus/4/.
Very few studies have examined gratting in
GEPRs/11,37/. Stevens/37/reported that grats of
fetal cerebellum containing gamma-aminobutyric
acid (GABA) neurons transplanted to the surface of
the inferior colliculus, or gratis of adrenal medulla
transplanted to the lateral ventricle are, in general,
ineffective in altering seizure expression in GEPRs.
However, an identifiable cerebellar graft was found
in only one of these animals upon autopsy and this
graft was encapsulated and not integrated with the
host brain. One of six rats with an adrenal medulla
gratt in the lateral ventricle showed a decrease in
seizure severity. Our laboratory has previously
reported that intraventricular or intrahippocampal
transplantation of fetal pontine tissue containing
noradrenergic neurons can effectively reduce
severity of seizures in a limited number of GEPR-3s
and GEPR-9s /11/. Grafting of fetal neurons has
also been demonstrated to suppress seizure
development in kindling-induced /1,2,25/ and
facilitate pentylenetetrazol-induced seizures in rats
with fimbria-fornix lesions/10/. Thus, grafted fetal
noradrenergic or cholinergic neurons can effectively
alter seizure expression in at least three models of
epilepsy. In the present study, immunohistochemical
detection of tyrosine hydroxylase (TH) in tissue
sections of the grafted brains demonstrated
numerous TH-positive neuron somata as well as
fibers within the grafted tissues and that TH positive
fibers invaded the parenchyma of the host brain
through the grat/host interface. Moreover, in some
cases, the densely packed clusters of neurons within
the grafted LC were similar to the cytoarchitecture
of the in situ locus coeruleus of control rats. The
present study demonstrates that, while Ctx gratis
grow to significantly larger size than LC gratis in
the third ventricle, grats containing the fetal LC are
significantly more effective than grafts of
neocortical tissue in reducing seizure severity in
GEPRs depleted of NE. Additionally, although not
statistically significant (likely due to the small
number of animals), LC gras appear to be more
effective in reducing seizure severity in NE-depleted
animals than in saline-treated LC-grafted animals.
Approximately 53% of animals receiving 6-OHDA
microinfusions and LC grafts showed significant
reductions in seizure severity. In animals that
displayed increases in seizure severity following 6-
OHDA, LC grats subsequently reduced the severity
to at least the pre-infusion level. In animals which
did not display an increase in seizure severity
following 6-OHDA, LC grafts effectively reduced
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seizure severity to below the preinfusion level and in
1 case completely abolished the display of AGS. In
contrast, of those rats receiving microinfusions of
saline into the LC, only 20% showed a decrease in
seizure severity following transplantation of fetal
LC tissue. These data suggest that the effectiveness
of noradrenergic neural gratis in promoting
reductions in seizure severity in GEPRs may be
increased when central NE is depleted by 6-OHDA.
It is a tenable hypothesis that depletion of central
NE with 6-OHDA creates a synaptic void in the
GEPR brain which promotes a more extensive
integration between the fetal LC grafts and the host
brains, increasing the potential to reduce seizure
severity. This hypothesis is not without precedence.
For example, hippocampal gratis in the anterior
chamber of the eye are more readily innervated by
LC co-grafts when competition from the host SCG
is removed by lesioning this structure in the host.
Additionally, it has been shown that neurite
outgrowth in vitro from catecholaminergic explant
cultures is much reduced in the presence of
exogenously administered L-dopa, a precursor of
NE/36/. These findings support the hypothesis that
there is a type of feedback inhibition on neurite
outgrowth and axon aborization from fetal grafts in
the presence of synaptic competition or neuro-
transmitter feedback from the host. However, the
hypothesis that development of NE fiber inter-
connections between the host and the grafted
tissues in animals with NE depletion has been
examined with LC grafts in the hippocampus/27/.
In this study, at two weeks following depletion of
NE in the host, there was no apparent difference in
graft-derived axon densities or synaptic profiles
between control animals and animals previously
depleted ofNE/27/
The observation that fetal LC grafts effectively
reduce seizure severity in a limited percentage of
animals raises questions about the mechanism of
this effect. It is presently unknown whether an
obligatory site for regulation of seizure severity is
innervated by NE neurons from the gaff, or
whether the release ofNE into the ventricular fluid
provides an anticonvulsant effect in the GEPR
through a more general mechanism. A previous
report found that gaffs of adrenal medulla tissue
had no effect when transplanted onto the surface of
the inferior colliculus, or into the lateral ventricle of
GEPRs /37/. However, microinjection of nor-
adrenergic agonists into the inferior colliculus also
fails to reduce seizure severity in GEPRs /6/,
suggesting that this is not the site at which NE
produces an anticonvulsant effect in the GEPR. In
other studies, we have shown that gratis of fetal LC
placed into the parenchyma of the hippocampus can
reduce seizure severity in limited numbers of
GEPR-3s and that LC grafts into the third ventricle
reduce seizure severity in both GEPR-9s and
GEPR-3s/11/. Moreover, this effect may be more
appreciable when the host brain is depleted of NE
(present study). The reductions in seizure severities
following gratting offetal LC into the third ventricle
support the findings of a seizure regulating site near
the ventricular surface. In a report by Stull and
colleagues /38/, near-ventricular terminal fields of
host NE axons have been implicated in the
regulation of electrically induced tonic extensor
seizures in non-epileptic rats, and several near-
ventricular areas of the brainstem have been
implicated in regulation of seizures in the GEPR
/19/. Thus, although the mechanism of action ofNE
gratis in the modification of seizure severity
requires further study, the apparent findings of
facilitated efficacy of fetal LC grafts to reduce
seizure severity following depletion of host NE
provide additional support for the anticonvulsant
effects ofNE in the epileptic brains as well as the
potential of fetal NE tissue gratis to modify the
severity of seizures. Furthermore, these studies
provide the impetus to continue to explore the
feasibility ofneuronal replacement with grafting in a
genetic model of epilepsy.
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